1009 Co-stimulatory signals via CD28 and CD27 collaborate to regulate activation and IL-2 production of CD8+ T Cells through distinct mechanisms

1009 Co-stimulatory signals via CD28 and CD27 collaborate to regulate activation and IL-2 production of CD8+ T Cells through distinct mechanisms

Bibliographic Details
Main Authors:	Ramon Arens, Juan Garcia Vallejo, Felix Behr, Anke Redeker, Suzanne Welten, Ward Vleeshouwers, Lucas Brock, Reza Nadafi, Floor van Haften, Elham Beyranvand Nejad, Ruud van Wijdeven
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Delayed vaccine-induced CD8+ T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication
by: Sjoerd H van der Burg, et al.
Published: (2023-11-01)

The viral context instructs the redundancy of costimulatory pathways in driving CD8+ T cell expansion
by: Suzanne PM Welten, et al.
Published: (2015-08-01)

Differential B7-CD28 costimulatory requirements for stable and inflationary mouse cytomegalovirus-specific memory CD8 T cell populations.
by: Arens, R, et al.
Published: (2011)

Properties of murine (CD8+)CD27- T cells.
by: Baars, P, et al.
Published: (2005)

Anti‐CLL1‐based CAR T‐cells with 4‐1‐BB or CD28/CD27 stimulatory domains in treating childhood refractory/relapsed acute myeloid leukemia
by: Kunlin Pei, et al.
Published: (2023-04-01)

CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab
by: Andre Kunert, et al.
Published: (2019-06-01)

CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development
by: Kenji Hashimoto
Published: (2021-05-01)

The immunological synapse and CD28-CD80 interactions.
by: Bromley, S, et al.
Published: (2001)

Modulation of CD27/CD70 co-stimulatory pathway may allow for the generation of a more potent human regulatory T cell product for cell therapy
by: Arroyo Hornero, R, et al.
Published: (2017)

Difference in Efficacy and Safety of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Containing 4-1BB and CD28 Co-Stimulatory Domains for B-Cell Acute Lymphoblastic Leukemia
by: Lijuan Wu, et al.
Published: (2023-05-01)

Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
by: Janina Świderska, et al.
Published: (2022-01-01)

CD8 and CD4 T Cell Populations in Human Kidneys
by: Carlos van der Putten, et al.
Published: (2021-02-01)

1357 CD27 is a new promising T cell co-stimulatory target for the cancer immunotherapy – development and selection of a lead anti-CD27 agonist antibody
by: Shawn Iadonato, et al.
Published: (2023-11-01)

Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.
by: Raychaudhuri, S, et al.
Published: (2009)

The hallmarks of CMV-specific CD8 T-cell differentiation.
by: Van Den Berg, S, et al.
Published: (2019)

Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2.
by: Webb, L, et al.
Published: (1996)

F-actin driven CD28-CD80 localization in the Immune Synapse
by: Meyer-Hermann, M, et al.
Published: (2018)

F-actin-driven CD28-CD80 localization in the immune synapse
by: Siokis, A, et al.
Published: (2018)

The Role of CD28 and CD8<sup>+</sup> T Cells in Keloid Development
by: Mengjie Shan, et al.
Published: (2022-08-01)

SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity
by: Panagiota Bouti, et al.
Published: (2023-12-01)

Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection.
by: Khalid, M, et al.
Published: (2012)

Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia
by: Raquel Delgado, et al.
Published: (2021-06-01)

Lower proportion of CD19+IL-10+ and CD19+CD24+CD27+ but not CD1d+CD5+CD19+CD24+CD27+ IL-10+ B cells in children with autoimmune thyroid diseases
by: Karolina Stożek, et al.
Published: (2020-01-01)

Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells
by: Kris Covens, et al.
Published: (2023-07-01)

Detection of senescent CD8+ T-lymphocyte in newly diagnosed and relapsed/refractory multiple myeloma using CD28 and CD57
by: Zahraa Mahdi Sareeh, et al.
Published: (2023-01-01)

Periferal Lökositlerde CD35, CD46, CD55 ve CD59 Düzeyleri
by: Aydan Karagül, et al.
Published: (2017-03-01)

Childhood acute lymphoblastic leukemia: Immunophenotypic profile and aberrant expression of CD13, CD33, CD117, CD11b, CD16, and CD64
by: Ihsan Mardan Al-Badran, et al.
Published: (2022-01-01)

The structure and cross-reactivity of CD28
by: Evans, E, et al.
Published: (2005)

Expansion of HIV-1-specific CD28- CD45RA- CD8+ T cells in chronically HIV-1-infected individuals.
by: Tomiyama, H, et al.
Published: (2000)

sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence
by: Andrea Aprilia, et al.
Published: (2024-01-01)

Differential expression of the costimulatory molecules CD86, CD28, CD152 and PD-1 correlates with the host-parasite outcome in leprosy
by: Maria de Lourdes Palermo, et al.
Published: (2012-12-01)

The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas
by: Luka de Vos, et al.
Published: (2020-11-01)

CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.
by: Jones, N, et al.
Published: (2000)

CD40-CD40L independent activation of CD8+T cells can trigger allograft rejection.
by: Jones, N, et al.
Published: (2000)

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells
by: Vinicio Melo, et al.
Published: (2023-07-01)

426 Anti-folate receptor alpha (FRα) CoStimulatory Antigen Receptor (CoStAR™) drives distinct cytokine-mediated proliferation responses in CD4+ and CD8+ T cells
by: Mark Dudley, et al.
Published: (2023-11-01)

Higher Expression of Activated CD8+ T Lymphocytes (CD8+CD25+, CD8+CD69+ and CD8+CD95+) Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients
by: Francisco Boix, et al.
Published: (2023-06-01)

Biophysical Characterization of CD6—TCR/CD3 Interplay in T Cells
by: Marjolein B. M. Meddens, et al.
Published: (2018-10-01)

Cross talk between CD3 and CD28 is spatially modulated by protein lateral mobility.
by: Bashour, K, et al.
Published: (2014)

CD28-CD80 Interactions Control Regulatory T Cell Motility and Immunological Synapse Formation.
by: Thauland, T, et al.
Published: (2014)